GT Biopharma, Inc. funding
GT Biopharma, Inc., a biotechnology company based in San Francisco, CA, filed a Form D with the SEC on September 29, 2026 and reported $7.8M raised of a $39M offering.
Amount raised$7.8M
Offering size$39M
Filed with the SECSeptember 29, 2026
First saleSeptember 14, 2026
IndustryBiotechnology
SecuritiesEquity
LocationSan Francisco, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far9
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Sep 29
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology